RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Back to Home
MFDS (South Korea)
NOTICE
「임상시험용의약품 표시 등에 관한 규정」 제정고시(안) 행정예고(식품의약품안전처 공고 제2026-540호)
Published: 11/5/2026Detected: 11/5/2026

Summary preview

Proposes and invites public comment on the enactment of a MFDS regulation governing labeling requirements for investigational medicinal products used in clinical trials.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
clinical
safety
labeling
#MFDS
#clinical trials
#investigational medicinal products
#labeling requirements
#administrative notice

Official Source Document
Source Verified

Access the original document directly from MFDS.

View Official Document

More from MFDS (South Korea)

  • 「축산물의 검사명령에 관한 규정」 제정고시(안) 행정예고(공고 제2026-542호, 2026.11.5)11/5/2026
  • 「위생용품의 자가품질검사 항목 및 세부 사항 지정」 일부개정고시(안) 행정예고(공고 제2026-520호, 2026.10.30.)10/30/2026
  • 체외진단의료기기 허가·신고·심사 등에 관한 규정 일부개정고시(안) 행정예고(공고 제2026 - 508호)10/29/2026
  • 「희귀의약품 지정에 관한 규정」 일부개정고시(안)(공고 제2026-522호, 2026.10.29.)10/29/2026
  • 「유전자변형식품등의 안전성 심사 등에 관한 규정」 일부개정고시(안) 행정예고(공고 제2026-519호, 2026.10.28)10/28/2026

Get MFDS (South Korea) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.